UBS Group
GNTA

UBS Group’s Genenta Science GNTA Stock Holding History

UBS Group’s Portfolio GNTA Stock Details GNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09K Sell
3,107
-309
-9% -$313 ﹤0.01% 9362
2025
Q4 		$5.09K Buy
+3,416
New +$8.04K ﹤0.01% 8725
2025
Q2 		– Sell
-91
Closed -$361 – 10474
2025
Q1 		$361 Buy
+91
New +$366 ﹤0.01% 9808
2024
Q4 		– Sell
-1,862
Closed -$7.95K – 10102
2024
Q3 		$7.95K Buy
1,862
+969
+109% +$3.89K ﹤0.01% 7865
2024
Q2 		$2.77K Buy
893
+852
+2,078% +$2.81K ﹤0.01% 8304
2024
Q1 		$144 Sell
41
-2,260
-98% -$9.27K ﹤0.01% 8784
2023
Q4 		$11.4K Buy
+2,301
New +$11.9K ﹤0.01% 7394
2023
Q3 		– Sell
-700
Closed -$4.13K – 9643
2023
Q2 		$4.13K Buy
+700
New +$4.15K ﹤0.01% 7566
2023
Q1 		– Sell
-3,215
Closed -$17.7K – 9874
2022
Q4 		$17.7K Buy
3,215
+187
+6% +$922 ﹤0.01% 7807
2022
Q3 		$15K Buy
3,028
+200
+7% +$1.19K ﹤0.01% 7796
2022
Q2 		$20K Buy
2,828
+865
+44% +$5.87K ﹤0.01% 6866
2022
Q1 		$14K Sell
1,963
-200
-9% -$1.61K ﹤0.01% 7938
2021
Q4 		$24K Buy
+2,163
New +$24.5K ﹤0.01% 7626

Other funds holding GNTA

ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
A
Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return
AG
AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

UBS Group's GNTA Position: Q1 2026 in Review

UBS Group reduced its Genenta Science (GNTA) stake by 9% in Q1 2026, selling an estimated $313 and leaving 3,107 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #9362.

UBS Group first reported a position in GNTA in Q4 2021 and has held it in 13 quarters since. The position peaked at $24K in Q4 2021. 11 funds tracked by Wall St. Rank hold GNTA as of Q1 2026.

  • UBS Group held 3,107 shares of Genenta Science worth $2.09K as of Q1 2026.
  • UBS Group sold 309 Genenta Science shares in Q1 2026, an estimated $313.
  • Genenta Science made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9362 holding.
  • UBS Group first reported a position in Genenta Science in Q4 2021 and has held it in 13 quarters since.
  • UBS Group's Genenta Science position peaked at $24K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Genenta Science as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.